Masood A. Khan

784 total citations
32 papers, 552 citations indexed

About

Masood A. Khan is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Masood A. Khan has authored 32 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Urology. Recurrent topics in Masood A. Khan's work include Urinary Bladder and Prostate Research (7 papers), Prostate Cancer Treatment and Research (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Masood A. Khan is often cited by papers focused on Urinary Bladder and Prostate Research (7 papers), Prostate Cancer Treatment and Research (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Masood A. Khan collaborates with scholars based in United Kingdom, United States and India. Masood A. Khan's co-authors include Anahi Perlas, Vincent Chan, Nicholas Mitsakakis, C.S. Thompson, Alan W. Partin, Jamie Y. Jeremy, R.J. Morgan, Faiz Mumtaz, Robert C. Calvert and Geoffrey Burnstock and has published in prestigious journals such as American Journal of Clinical Nutrition, Science Advances and The Journal of Urology.

In The Last Decade

Masood A. Khan

31 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masood A. Khan United Kingdom 11 235 118 111 99 77 32 552
Jason Joseph United States 11 144 0.6× 239 2.0× 43 0.4× 84 0.8× 32 0.4× 32 545
Moshe Katz Israel 16 203 0.9× 162 1.4× 20 0.2× 96 1.0× 25 0.3× 42 576
Lila Papadimitriou Greece 11 195 0.8× 129 1.1× 19 0.2× 78 0.8× 64 0.8× 17 569
J.M. Gaya Spain 13 264 1.1× 62 0.5× 77 0.7× 188 1.9× 24 0.3× 45 648
Erling Bjerregaard Pedersen Denmark 13 108 0.5× 66 0.6× 142 1.3× 209 2.1× 27 0.4× 30 566
Robert O’Shea United States 14 265 1.1× 36 0.3× 24 0.2× 53 0.5× 67 0.9× 33 858
Şahin Kabay Türkiye 14 124 0.5× 12 0.1× 358 3.2× 76 0.8× 61 0.8× 34 687
Ali Naycı Türkiye 14 233 1.0× 21 0.2× 67 0.6× 128 1.3× 8 0.1× 64 561
Dorothee Decker Germany 9 225 1.0× 33 0.3× 6 0.1× 90 0.9× 70 0.9× 10 556

Countries citing papers authored by Masood A. Khan

Since Specialization
Citations

This map shows the geographic impact of Masood A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masood A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masood A. Khan more than expected).

Fields of papers citing papers by Masood A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masood A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masood A. Khan. The network helps show where Masood A. Khan may publish in the future.

Co-authorship network of co-authors of Masood A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Masood A. Khan. A scholar is included among the top collaborators of Masood A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masood A. Khan. Masood A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Shawn, et al.. (2025). EFFECT OF TIME-TO-SURGERY ON DISTAL RADIUS FRACTURE OUTCOMES: A SYSTEMATIC REVIEW. Orthopaedic Proceedings. 107-B(SUPP_13). 91–91.
2.
Krietenstein, Nils, et al.. (2024). Genome wide nucleosome landscape shapes 3D chromatin organization. Science Advances. 10(23). eadn2955–eadn2955. 1 indexed citations
3.
Vadakekolathu, Jayakumar, Stephen Reeder, Masood A. Khan, et al.. (2022). A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice. Cancers. 14(8). 1970–1970. 2 indexed citations
4.
Khan, Masood A., et al.. (2021). Thulium laser vapo-enucleation treatment for prostates >100 cc following urinary retention. Urologia Journal. 89(3). 378–381. 1 indexed citations
5.
Cai, Hong, Edwina N. Scott, Robert G. Britton, et al.. (2020). Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity?. American Journal of Clinical Nutrition. 113(5). 1115–1125. 13 indexed citations
7.
Rajesh, Arumugam, et al.. (2013). Bosniak IIF renal cysts: is there a malignancy potential?. Journal of Clinical Urology. 6(2). 106–109. 2 indexed citations
9.
Perlas, Anahi, et al.. (2011). Gastric Sonography in the Fasted Surgical Patient. Anesthesia & Analgesia. 113(1). 93–97. 203 indexed citations
10.
Pal, Raj P. & Masood A. Khan. (2011). Intermediate-Term Efficacy of Tm:YAG Laser Prostate Vaporesection for Bladder Outlet Obstruction: Initial Experience from a UK Teaching Hospital. Urologia Internationalis. 88(1). 39–42. 3 indexed citations
11.
Pal, Raj P., Tim Terry, & Masood A. Khan. (2009). Spontaneous Intra-Peritoneal Perforation of the Bladder Secondary to Peritoneal Tuberculosis. 2(5). 213–214. 3 indexed citations
12.
Calvert, Robert C., Masood A. Khan, Cecil S. Thompson, Dimitri P. Mikhailidis, & Geoffrey Burnstock. (2008). A functional study of purinergic signalling in the normal and pathological rabbit corpus cavernosum. British Journal of Urology. 101(8). 1043–1047. 15 indexed citations
13.
Veltri, Robert W., Cameron Marlow, Masood A. Khan, et al.. (2007). Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis. The Prostate. 67(11). 1202–1210. 21 indexed citations
14.
Veltri, Robert W., Masood A. Khan, Cameron Marlow, et al.. (2006). Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer. Urology. 68(4). 898–904. 8 indexed citations
15.
Khan, Masood A. & Alan W. Partin. (2004). Vasectomy and prostate cancer.. PubMed. 6(1). 46–7. 2 indexed citations
16.
Khan, Masood A. & Alan W. Partin. (2004). Endothelin-a receptor antagonists and advanced prostate cancer.. PubMed. 6(1). 47–8. 3 indexed citations
17.
Khan, Masood A. & Alan W. Partin. (2003). Bisphosphonates in metastatic prostate cancer.. PubMed. 5(3). 204–6. 4 indexed citations
18.
Khan, Masood A., et al.. (2002). Effect of the Rate of Delivery of Lignocaine Gel on Patient Discomfort Perception prior to Performing Flexible Cystoscopy. Urologia Internationalis. 68(3). 164–167. 26 indexed citations
19.
Khan, Masood A., et al.. (2001). The effect of superoxide dismutase on nitric oxide‐mediated and electrical field‐stimulated diabetic rabbit cavernosal smooth muscle relaxation. British Journal of Urology. 87(1). 98–103. 58 indexed citations
20.
Khan, Masood A., et al.. (2000). Testicular Seminoma in a Man with Bilateral Microlithiasis and a History of Cryptorchidism. Scandinavian Journal of Urology and Nephrology. 34(6). 377–379. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026